Summary of clinical data corresponding to HIV+ subjects enrolled per study group.

aVersant HIV-1 RNA 3.0 assay, Siemens. Lower and upper detection limits are 50 and 500,000 RNA copies/ml, respectively (1.7 and 5.7log10).bFlow cytometry double platform, FACSCanto, BD Biosciences.cFor PHI subjects, data correspond to baseline samples. For chronic and elite controller subjects, data correspond to samples obtained at enrollment.dSet points were not calculated for subjects that initiated HAART during the first year post-infection.IQ: Interquartile range.